350 related articles for article (PubMed ID: 34381313)
1. Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review.
An Y; Zhou J; Lin G; Wu H; Cong L; Li Y; Qiu X; Shi W
Pathol Oncol Res; 2021; 27():1609859. PubMed ID: 34381313
[TBL] [Abstract][Full Text] [Related]
2. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
Kim H; Kim BH; Lee D; Shin E
Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.
Kakar S; Deng G; Smyrk TC; Cun L; Sahai V; Kim YS
Mod Pathol; 2012 Jul; 25(7):1040-7. PubMed ID: 22522845
[TBL] [Abstract][Full Text] [Related]
4. Signet-ring cell carcinoma of colorectum--current perspectives and molecular biology.
Gopalan V; Smith RA; Ho YH; Lam AK
Int J Colorectal Dis; 2011 Feb; 26(2):127-33. PubMed ID: 20686774
[TBL] [Abstract][Full Text] [Related]
5. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
6. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
Korphaisarn K; Morris V; Davis JS; Overman MJ; Fogelman DR; Kee BK; Dasari A; Raghav KPS; Shureiqi I; Trupti M; Wolff RA; Eng C; Menter DG; Hamilton S; Kopetz S
Br J Cancer; 2019 Sep; 121(6):505-510. PubMed ID: 31406299
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.
Alvi MA; Loughrey MB; Dunne P; McQuaid S; Turkington R; Fuchs MA; McGready C; Bingham V; Pang B; Moore W; Maxwell P; Lawler M; James JA; Murray GI; Wilson RH; Salto-Tellez M
Br J Cancer; 2017 Jul; 117(2):203-209. PubMed ID: 28595259
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK
Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
Nosho K; Shima K; Irahara N; Kure S; Firestein R; Baba Y; Toyoda S; Chen L; Hazra A; Giovannucci EL; Fuchs CS; Ogino S
Mod Pathol; 2009 Jul; 22(7):922-32. PubMed ID: 19430421
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
[TBL] [Abstract][Full Text] [Related]
11. Colorectal signet ring cell carcinoma: Influence of EGFR, E-cadherin and MMP-13 expression on clinicopathological features and prognosis.
Foda AAM; Aziz AA; Mohamed MA
Ann Diagn Pathol; 2018 Feb; 32():41-46. PubMed ID: 29414397
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component.
Wei Q; Wang X; Gao J; Li J; Li J; Qi C; Li Y; Li Z; Shen L
PLoS One; 2016; 11(6):e0156659. PubMed ID: 27300552
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
[TBL] [Abstract][Full Text] [Related]
15. Primary signet ring cell carcinoma of the colon and rectum.
Arifi S; Elmesbahi O; Amarti Riffi A
Bull Cancer; 2015 Oct; 102(10):880-8. PubMed ID: 26412710
[TBL] [Abstract][Full Text] [Related]
16. The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma.
Wang R; Ma X; Li Y; He Y; Huang D; Cai S; Peng J
PLoS One; 2016; 11(8):e0160527. PubMed ID: 27509205
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S
PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263
[TBL] [Abstract][Full Text] [Related]
18. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
19. The Molecular Associations of Signet-Ring Cell Carcinoma in Colorectum: Meta-Analysis and System Review.
Liu X; Huang L; Liu M; Wang Z
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888555
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma.
Tajiri K; Sudou T; Fujita F; Hisaka T; Kinugasa T; Akagi Y
Anticancer Res; 2017 Jul; 37(7):3817-3823. PubMed ID: 28668881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
